HRS Investment Holdings’s Bristol-Myers Squibb BMY Stock Holding History

HRS Investment Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-27,500	Closed	-$1.43M	–	10
2018 Q4	$1.43M	Sell	27,500 -7,500	-21%	-$403K	0.79%	33
2018 Q3	$2.17M	Hold	35,000	–	–	1%	28
2018 Q2	$1.94M	Sell	35,000 -7,500	-18%	-$405K	0.97%	35
2018 Q1	$2.69M	Buy	42,500 +5,000	+13%	+$322K	1.31%	20
2017 Q4	$2.3M	Hold	37,500	–	–	1.21%	24
2017 Q3	$2.39M	Sell	37,500 -2,500	-6%	-$146K	1.44%	16
2017 Q2	$2.23M	Hold	40,000	–	–	1.46%	18
2017 Q1	$2.17M	Buy	40,000 +2,500	+7%	+$137K	1.57%	19
2016 Q4	$2.19M	Hold	37,500	–	–	1.77%	17
2016 Q3	$2.02M	Buy	37,500 +15,000	+67%	+$964K	1.86%	18
2016 Q2	$1.66M	Buy	22,500 +2,500	+13%	+$177K	1.58%	28
2016 Q1	$1.28M	Hold	20,000	–	–	1.2%	39
2015 Q4	$1.38M	Buy	+20,000	New	+$1.32M	1.32%	33

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

HRS Investment Holdings's BMY Position: Q1 2019 in Review

HRS Investment Holdings sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 27,500 shares — an estimated $1.43M sold.

HRS Investment Holdings first reported a position in BMY in Q4 2015 and held it in 13 quarters. The position peaked at $2.69M in Q1 2018. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

HRS Investment Holdings reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
HRS Investment Holdings sold 27,500 Bristol-Myers Squibb shares in Q1 2019, an estimated $1.43M.
HRS Investment Holdings first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 13 quarters.
HRS Investment Holdings's Bristol-Myers Squibb position peaked at $2.69M in Q1 2018.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on HRS Investment Holdings's 13F filing for Q1 2019, filed 15 May 2019.